These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 21911457)
41. Combination of AAV-TRAIL with miR-221-Zip Therapeutic Strategy Overcomes the Resistance to TRAIL Induced Apoptosis in Liver Cancer. Ma S; Sun J; Guo Y; Zhang P; Liu Y; Zheng D; Shi J Theranostics; 2017; 7(13):3228-3242. PubMed ID: 28900506 [TBL] [Abstract][Full Text] [Related]
42. Hypermethylation of the death-associated protein kinase promoter attenuates the sensitivity to TRAIL-induced apoptosis in human non-small cell lung cancer cells. Tang X; Wu W; Sun SY; Wistuba II; Hong WK; Mao L Mol Cancer Res; 2004 Dec; 2(12):685-91. PubMed ID: 15634757 [TBL] [Abstract][Full Text] [Related]
43. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo. Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Gschwend JE; Simmet T; Debatin KM; Fulda S Cancer Res; 2008 Oct; 68(19):7956-65. PubMed ID: 18829553 [TBL] [Abstract][Full Text] [Related]
44. beta-Ionone enhances TRAIL-induced apoptosis in hepatocellular carcinoma cells through Sp1-dependent upregulation of DR5 and downregulation of NF-kappaB activity. Kim MO; Moon DO; Kang CH; Kwon TK; Choi YH; Kim GY Mol Cancer Ther; 2010 Apr; 9(4):833-43. PubMed ID: 20354117 [TBL] [Abstract][Full Text] [Related]
45. BAY61-3606 potentiates the anti-tumor effects of TRAIL against colon cancer through up-regulating DR4 and down-regulating NF-κB. Du J; Wang Y; Chen D; Ji G; Ma Q; Liao S; Zheng Y; Zhang J; Hou Y Cancer Lett; 2016 Dec; 383(2):145-153. PubMed ID: 27721019 [TBL] [Abstract][Full Text] [Related]
46. The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells. Kauntz H; Bousserouel S; Gossé F; Raul F Apoptosis; 2012 Aug; 17(8):797-809. PubMed ID: 22555452 [TBL] [Abstract][Full Text] [Related]
47. Knockdown of HURP inhibits the proliferation of hepacellular carcinoma cells via downregulation of gankyrin and accumulation of p53. Kuo TC; Chang PY; Huang SF; Chou CK; Chao CC Biochem Pharmacol; 2012 Mar; 83(6):758-68. PubMed ID: 22230478 [TBL] [Abstract][Full Text] [Related]
48. SUV39H1 regulates human colon carcinoma apoptosis and cell cycle to promote tumor growth. Lu C; Klement JD; Yang D; Albers T; Lebedyeva IO; Waller JL; Liu K Cancer Lett; 2020 Apr; 476():87-96. PubMed ID: 32061753 [TBL] [Abstract][Full Text] [Related]
49. Cisplatin sensitizes human hepatocellular carcinoma cells, but not hepatocytes and mesenchymal stem cells, to TRAIL within a therapeutic window partially depending on the upregulation of DR5. Zhang B; Shan H; Li D; Li ZR; Zhu KS; Jiang ZB; Huang MS Oncol Rep; 2011 Feb; 25(2):461-8. PubMed ID: 21152876 [TBL] [Abstract][Full Text] [Related]
50. Icariin sensitizes human colon cancer cells to TRAIL‑induced apoptosis via ERK‑mediated upregulation of death receptors. Kim B; Seo JH; Lee KY; Park B Int J Oncol; 2020 Mar; 56(3):821-834. PubMed ID: 32124960 [TBL] [Abstract][Full Text] [Related]
51. Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer. Okami J; Simeone DM; Logsdon CD Cancer Res; 2004 Aug; 64(15):5338-46. PubMed ID: 15289340 [TBL] [Abstract][Full Text] [Related]
52. GSTP1 determines cis-platinum cytotoxicity in gastric adenocarcinoma MGC803 cells: regulation by promoter methylation and extracellular regulated kinase signaling. Zhang Y; Qu X; Jing W; Hu X; Yang X; Hou K; Teng Y; Zhang J; Liu Y Anticancer Drugs; 2009 Mar; 20(3):208-14. PubMed ID: 19396019 [TBL] [Abstract][Full Text] [Related]
53. Expression of anti-apoptotic factors modulates Apo2L/TRAIL resistance in colon carcinoma cells. Lippa MS; Strockbine LD; Le TT; Branstetter DG; Strathdee CA; Holland PM Apoptosis; 2007 Aug; 12(8):1465-78. PubMed ID: 17440816 [TBL] [Abstract][Full Text] [Related]
54. Enzymatically active cathepsin D sensitizes breast carcinoma cells to TRAIL. Jancekova B; Ondrouskova E; Knopfova L; Smarda J; Benes P Tumour Biol; 2016 Aug; 37(8):10685-96. PubMed ID: 26867770 [TBL] [Abstract][Full Text] [Related]
55. Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma. Chen MC; Huang HH; Lai CY; Lin YJ; Liou JP; Lai MJ; Li YH; Teng CM; Yang CR Oncotarget; 2016 Jan; 7(1):402-17. PubMed ID: 26587975 [TBL] [Abstract][Full Text] [Related]
56. Sperm associated antigen 9 (SPAG9) a promising therapeutic target of ovarian carcinoma. Jagadish N; Fatima R; Sharma A; Devi S; Suri V; Kumar V; Suri A Tumour Biol; 2018 May; 40(5):1010428318773652. PubMed ID: 29745297 [TBL] [Abstract][Full Text] [Related]
57. EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by increasing PTEN expression. Selvendiran K; Tong L; Vishwanath S; Bratasz A; Trigg NJ; Kutala VK; Hideg K; Kuppusamy P J Biol Chem; 2007 Sep; 282(39):28609-28618. PubMed ID: 17684018 [TBL] [Abstract][Full Text] [Related]
58. Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers. Yuan BZ; Durkin ME; Popescu NC Cancer Genet Cytogenet; 2003 Jan; 140(2):113-7. PubMed ID: 12645648 [TBL] [Abstract][Full Text] [Related]
59. Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5). Jung EM; Lim JH; Lee TJ; Park JW; Choi KS; Kwon TK Carcinogenesis; 2005 Nov; 26(11):1905-13. PubMed ID: 15987718 [TBL] [Abstract][Full Text] [Related]
60. Epigenetic Regulation of Apoptosis and Cell Cycle Regulatory Genes in Human Colon Carcinoma Cells. Paschall AV; Liu K Genom Data; 2015 Sep; 5():189-191. PubMed ID: 26309812 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]